Z650 not checked

Sunshine Lake Pharma Co., Ltd.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
1 active
6 in total
Targets
 

What this is

How it works
How it works isn't classified yet
Tested for
Esophageal Cancer
Main trialPhase 3
“This is a randomized, controlled, multi-center, open trial, unresectable locally advanced or metastatic esophageal squamous cell carcinoma patients that failed at least second-line treatment and overexpressed EGFR were enrolled and randomly assigned to the experimental group and control group at a 1: 1 ratio.,who received Larotinib and the chemotherapy regimen chosen by the investigator (Irinotecan Hydrochloride Injection or Tegafur Gimeracil Oteracil Potassium Capsule),respecitively. Subjects are administered until disease progression assessed by the RECIST V1.1 standard (unless the…”In the company’s words, NCT04415853 on ClinicalTrials.gov
Other names
Larotinib · Lerotinib

Other drugs for Esophageal Cancer

All 138 drugs for Esophageal Cancer

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials6

TrialPhaseCompletesWhat it tests
Phase 3Recruiting Aug 2027 Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer
Phase 1/2Completed 13 Dec 2022 Z650 in Advanced Esophageal Squamous Cell Carcinoma With EGFR Over Expression or Gene Amplification
Phase 1Terminated 9 Sep 2021 Gemcitabine and Z650 in Treating Patients With Metastatic or Recurrent Pancreatic Cancer
Phase 1Completed 10 Jan 2022 ADME Study of [14C]- Larotinib in Healthy Male Subjects
Phase 1Completed 17 Feb 2022 A Study to Evaluate Drug-Drug Interaction of Larotinib With Itraconazole and Rifampin in Healthy Adult Participants
Phase 1Withdrawn 30 Dec 2026 Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic Function
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Z650

Following is part of Solo: you see every change to Z650 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in